Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...
The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...
Mr. Shinichi Tamura, Mr. Tomohiro Tohyama and Mr. Kuniaki Kaga to retire from the Board of Directors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback